Clinical trial
Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine
NCT05053321 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- October 18, 2024
- Completion date
- October 18, 2025
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.